Author:
Wendtner C-M, ,Ritgen M,Schweighofer C D,Fingerle-Rowson G,Campe H,Jäger G,Eichhorst B,Busch R,Diem H,Engert A,Stilgenbauer S,Döhner H,Kneba M,Emmerich B,Hallek M
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference45 articles.
1. Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1750–1757.
2. Leporrier M, Chevret S, Cazin B, Boudjerra N, Feugier P, Desablens B et al. Randomized comparison of fludarabine, CAP and CHOP, in 938 previously treated stage B and C chronic lymphocytic leukemia. Blood 2001; 98: 2319–2325.
3. O'Brien SM, Kantarjian HM, Cortes J, Beran M, Koller CA, Giles FJ et al. Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. J Clin Oncol 2001; 19: 1414–1420.
4. Hallek M, Schmitt B, Wilhelm M, Busch R, Krober A, Fostitsch HP et al. Fludarabine plus cyclophospamide is an efficient treatment for advanced chronic lymphocytic leukemia: results of a phase II study of the German CLL Study Group. Br J Hematol 2001; 11: 1–8.
5. Dreger P, Montserrat E . Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia. Leukemia 2002; 16: 985–992.
Cited by
224 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献